Kravitz, R L <br/><br/>
Direct-to-consumer advertising of prescription drugs: balancing benefits and risks, and a way forward.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Oct 2007 
 - 360-2 p.  digital 
<br/><br/> Publication Type: Comment; Journal Article 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1038/sj.clpt.6100348  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Consumer Product Safety<br/>Drug Industry--economics<br/>Drug Information Services--economics<br/>Drug Prescriptions<br/>Drug Therapy--economics<br/>Drug and Narcotic Control<br/>Drug-Related Side Effects and Adverse Reactions<br/>Health Knowledge, Attitudes, Practice<br/>Health Promotion<br/>Humans<br/>Marketing of Health Services--economics<br/>Mass Media<br/>Models, Econometric<br/>Patient Education as Topic<br/>Persuasive Communication<br/>Physician's Role<br/>Practice Patterns, Physicians'<br/>Product Surveillance, Postmarketing<br/>Risk Assessment